WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹643 Cr | ₹882 Cr | ₹866 Cr | ₹840 Cr | ₹639 Cr |
What is the latest Contingent Liabilities ratio of WOCKHARDT ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹643 Cr |
| Mar2024 | ₹882 Cr |
| Mar2023 | ₹866 Cr |
| Mar2022 | ₹840 Cr |
| Mar2021 | ₹639 Cr |
How is Contingent Liabilities of WOCKHARDT Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹643 Cr | -27.11 | |
| Mar2024 | ₹882 Cr | 1.87 | |
| Mar2023 | ₹866 Cr | 3.13 | |
| Mar2022 | ₹840 Cr | 31.46 | |
| Mar2021 | ₹639 Cr | - | |
Compare Contingent Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹21,364.7 Cr | -3.1% | -7.5% | 6.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,828.0 Cr | 1.2% | -5.3% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,227.0 Cr | -3.9% | -6% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,045.0 Cr | 0.9% | 3.7% | 20.5% | Stock Analytics | |
| CIPLA | ₹105,961.0 Cr | -1.2% | -12.6% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,682.5 Cr | -3.4% | -5.7% | 0.3% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -3.1% |
-7.5% |
6.2% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses